Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: Modelling study

BMJ (Online)

Volumn 358, Issue , 2017, Pages

  Ahmadi Abhari, Sara ^a   Guzman Castillo, Maria ^b   Bandosz, Piotr ^b,c   Shipley, Martin J ^a   Muniz Terrera, Graciela ^d   Singh Manoux, Archana ^a,e   Kivimäki, Mika ^a,f   Steptoe, Andrew ^a   Capewell, Simon ^b   O'flaherty, Martin ^b   Brunner, Eric J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e HÔPITAL PAUL BROUSSE   (France)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COGNITION; DEMENTIA; DISEASE PREDISPOSITION; ENGLAND; FEMALE; FUNCTIONAL DISEASE; HIDDEN MARKOV MODEL; HUMAN; LIFE EXPECTANCY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; PREVALENCE; PRIORITY JOURNAL; TREND STUDY; WALES; AGED; HEALTH SURVEY; INCIDENCE; MIDDLE AGED; SEX RATIO; SOCIOECONOMICS; THEORETICAL MODEL; TIME FACTOR;

AGED; DEMENTIA; ENGLAND; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; LIFE EXPECTANCY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, THEORETICAL; POPULATION SURVEILLANCE; PREVALENCE; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; TIME FACTORS; WALES;

EID: 85022209593     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.j2856     Document Type: Article

References (56)

1. World Alzheimer report 2015. The global impact of dementia, an analysis of prevalence, incidence, cost and trends. 2015. Alzheimer?s Disease International
2. Dementia UK. A report into the prevalence and cost of dementia prepared by the Personal Social Services Unit (PSSRU) at the London School of Economics and the Institute of Psychiatry at King?s College London, for the Alzheimer?s society.Alzheimer's Society, 2007.
3. Murray CJ, Richards MA, Newton JN, et al. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013; 381: 997-1020. doi: 10.1016/S0140-6736(13)60355-4.
4. Norton S, Matthews FE, Brayne C. A commentary on studies presenting projections of the future prevalence of dementia. BMC Public Health 2013; 13: 1. doi: 10.1186/1471-2458-13-1.
5. Prince M, Ali GC, Guerchet M, Prina AM, Albanese E, Wu YT. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther 2016; 8: 23-0188. doi: 10.1186/s13195-016-0188-8.
6. Wanneveich M, Jacqmin-Gadda H, Dartigues JF, Joly P. Impact of intervention targeting risk factors on chronic disease burden. Stat Methods Med Res 2016; Mar 17: 0962280216631360.
7. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer?s disease prevalence. Lancet Neurol 2011; 10: 819-28. doi: 10.1016/S1474-4422(11)70072-2.
8. Brunner EJ, Welch CA, Shipley MJ, Ahmadi-Abhari S, Singh-Manoux A, Kivimaki M. Midlife risk factors for impaired physical and cognitive functioning at older ages: a cohort study. J Gerontol A Biol Sci Med Sci 2017; 72: 237-42.
9. Bennett JE, Li G, Foreman K, et al. The future of life expectancy and life expectancy inequalities in England and Wales: Bayesian spatiotemporal forecasting. Lancet 2015; 386: 163-70. doi: 10.1016/S0140-6736(15)60296-3.
10. NICE guideline. Dementia, disability and frailty in later life: mid-life approaches to delay or prevent onset. 20-10-2015.
11. Lincoln P, Fenton K, Alessi C, et al. The Blackfriars Consensus on brain health and dementia. Lancet 2014; 383: 1805-6. doi: 10.1016/S0140-6736(14)60758-3.
12. Schrijvers EM, Verhaaren BF, Koudstaal PJ, Hofman A, Ikram MA, Breteler MM. Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology 2012; 78: 1456-63. doi: 10.1212/WNL.0b013e3182553be6.
13. Matthews FE, Stephan BC, Robinson L, et al. Cognitive Function and Ageing Studies (CFAS) Collaboration. A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nat Commun 2016; 7: 11398. doi: 10.1038/ncomms11398.
14. Rocca WA, Petersen RC, Knopman DS, et al. Trends in the incidence and prevalence of Alzheimer?s disease, dementia, and cognitive impairment in the United States. Alzheimers Dement 2011; 7: 80-93. doi: 10.1016/j.jalz.2010.11.002.
15. Qiu C, von Strauss E, Bäckman L, Winblad B, Fratiglioni L. Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology 2013; 80: 1888-94. doi: 10.1212/WNL.0b013e318292a2f9.
16. Doblhammer G, Fink A, Zylla S, Willekens F. Compression or expansion of dementia in Germany? An observational study of short-Term trends in incidence and death rates of dementia between 2006/07 and 2009/10 based on German health insurance data. Alzheimers Res Ther 2015; 7: 66-0146. doi: 10.1186/s13195-015-0146-x.
17. Grasset L, Brayne C, Joly P, et al. Trends in dementia incidence: Evolution over a 10-year period in France. Alzheimers Dement 2016; 12: 272-80. doi: 10.1016/j.jalz.2015.11.001.
18. Satizabal CL, Beiser AS, Chouraki V, Chêne G, Dufouil C, Seshadri S. Incidence of Dementia over Three Decades in the Framingham Heart Study. N Engl J Med 2016; 374: 523-32. doi: 10.1056/NEJMoa1504327.
19. Prince M, Ferri CP, Acosta D, et alThe protocols for the 10/66 dementia research group population-based research programme. BMC Public Health 2007; 7: 165.
20. Matthews FE, Arthur A, Barnes LE, et al. Medical Research Council Cognitive Function and Ageing Collaboration. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 2013; 382: 1405-12. doi: 10.1016/S0140-6736(13)61570-6.
21. Langa KM, Larson EB, Karlawish JH, et al. Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity?Alzheimers Dement 2008; 4: 134-44. doi: 10.1016/j.jalz.2008.01.001.
22. Prince MJ, de Rodriguez JL, Noriega L, et al. 10/66 Dementia research group. The 10/66 Dementia Research Group?s fully operationalised DSM-IV dementia computerized diagnostic algorithm, compared with the 10/66 dementia algorithm and a clinician diagnosis: a population validation study. BMC Public Health 2008; 8: 219. doi: 10.1186/1471-2458-8-219.
23. Baldereschi M, Amato MP, Nencini P, et al. Cross-national interrater agreement on the clinical diagnostic criteria for dementia. WHO-PRA Age-Associated Dementia Working Group, WHO-Program for Research on Aging, Health of Elderly Program. Neurology 1994; 44: 239-42. doi: 10.1212/WNL.44.2.239.
24. Knopman DS, Roberts RO, Pankratz VS, et al. Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging. Am J Epidemiol 2014; 180: 414-23. doi: 10.1093/aje/kwu103.
25. Binder N, Schumacher M, Joly P. Re: Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging. Am J Epidemiol 2015; 181: 291-2. doi: 10.1093/aje/kwu475.
26. Rizopoulos D. Joint models for longitudinal and time-To-event data, with applications in R. Chapman and Hall / CRC press, 2012doi: 10.1201/b12208.
27. Steptoe A, Breeze E, Banks J, Nazroo J. Cohort profile: the English longitudinal study of ageing. Int J Epidemiol 2013; 42: 1640-8. doi: 10.1093/ije/dys168.
28. Mindell J, Biddulph JP, Hirani V, et al. Cohort profile: the health survey for England. Int J Epidemiol 2012; 41: 1585-93. doi: 10.1093/ije/dyr199.
29. Harrison JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting. Cochrane Database Syst Rev 2015; 3: CD010772. doi: 10.1002/14651858.CD010772.pub2.: CD010772.
30. Chertkow H, Nasreddine Z, Joanette Y, et al. Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis. Alzheimers Dement 2007; 3: 266-82. doi: 10.1016/j.jalz.2007.07.013.
31. Haller B, Schmidt G, Ulm K. Applying competing risks regression models: an overview. Lifetime Data Anal 2013; 19: 33-58. doi: 10.1007/s10985-012-9230-8.
32. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer 2004; 91: 1229-35. doi: 10.1038/sj.bjc.6602102.
33. Guzman Castillo M, Gillespie DO, Allen K, et al. Future declines of coronary heart disease mortality in England and Wales could counter the burden of population ageing. PLoS One 2014; 9: e99482. doi: 10.1371/journal.pone.0099482.
34. Health Survey for England 2011. 20-12-2012. Health and social care information centre
35. Nepal B, Brown L, Ranmuthugala G. Modelling the impact of modifying lifestyle risk factors on dementia prevalence in Australian population aged 45 years and over, 2006-2051. Australas J Ageing 2010; 29: 111-6. doi: 10.1111/j.1741-6612.2010.00392.x.
36. Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013; 80: 1778-83. doi: 10.1212/WNL.0b013e31828726f5.
37. Comas-Herrera A, Wittenberg R, Pickard L, Knapp M. Cognitive impairment in older people: future demand for long-Term care services and the associated costs. Int J Geriatr Psychiatry 2007; 22: 1037-45. doi: 10.1002/gps.1830.
38. Singh-Manoux A, Kivimaki M, Glymour MM, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ 2012; 344: d7622. doi: 10.1136/bmj.d7622.
39. Noale M, Limongi F, Zambon S, Crepaldi G, Maggi S. ILSA Working Group. Incidence of dementia: evidence for an effect modification by gender. The ILSA Study. Int Psychogeriatr 2013; 25: 1867-76. doi: 10.1017/S1041610213001300.
40. Bermejo-Pareja F, Benito-León J, Vega S, Medrano MJ, Román GC. Neurological Disorders in Central Spain (NEDICES) Study Group. Incidence and subtypes of dementia in three elderly populations of central Spain. J Neurol Sci 2008; 264: 63-72. doi: 10.1016/j. jns.2007.07.021.
41. Fitzpatrick AL, Kuller LH, Ives DG, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 2004; 52: 195-204. doi: 10.1111/j.1532-5415.2004.52058.x.
42. Stephan BC, Kurth T, Matthews FE, Brayne C, Dufouil C. Dementia risk prediction in the population: are screening models accurate?Nat Rev Neurol 2010; 6: 318-26. doi: 10.1038/nrneurol.2010.54.
43. Lonie JA, Tierney KM, Ebmeier KP. Screening for mild cognitive impairment: a systematic review. Int J Geriatr Psychiatry 2009; 24: 902-15. doi: 10.1002/gps.2208.
44. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994; 44: 1427-32. doi: 10.1212/WNL.44.8.1427.
45. Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A. Detection and staging of dementia in Alzheimer?s disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer?s Disease. Arch Neurol 1992; 49: 448-52. doi: 10.1001/archneur.1992.00530290030008.
46. Mendoza W, Miranda JJ. Global Shifts in Cardiovascular Disease, the Epidemiologic Transition, and Other Contributing Factors: Toward a New Practice of Global Health Cardiology. Cardiol Clin 2017; 35: 1-12. doi: 10.1016/j.ccl.2016.08.004.
47. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385: 117-71. doi: 10.1016/S0140-6736(14)61682-2.
48. Lewis FI, Torgerson PR. The current and future burden of late-onset dementia in the United Kingdom: Estimates and interventions. Alzheimers Dement 2017; 13: 38-44. doi: 10.1016/j.jalz.2016.03.013.
49. Wu YT, Fratiglioni L, Matthews FE, et al. Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol 2015; 15: 10-4422.
50. Lobo A, Saz P, Marcos G, et al. ZARADEMP Workgroup. Prevalence of dementia in a southern European population in two different time periods: the ZARADEMP Project. Acta Psychiatr Scand 2007; 116: 299-307. doi: 10.1111/j.1600-0447.2007.01006.x.
51. Wu YT, Lee HY, Norton S, et al. Period, birth cohort and prevalence of dementia in mainland China, Hong Kong and Taiwan: a meta-Analysis. Int J Geriatr Psychiatry 2014; 29: 1212-20. doi: 10.1002/gps.4148.
52. Sekita A, Ninomiya T, Tanizaki Y, et al. Trends in prevalence of Alzheimer?s disease and vascular dementia in a Japanese community: the Hisayama Study. Acta Psychiatr Scand 2010; 122: 319-25. doi: 10.1111/j.1600-0447.2010.01587.x.
53. Hardoon SL, Morris RW, Whincup PH, et al. Rising adiposity curbing decline in the incidence of myocardial infarction: 20-year follow-up of British men and women in the Whitehall II cohort. Eur Heart J 2012; 33: 478-85. doi: 10.1093/eurheartj/ehr142.
54. Gauthier S, Albert M, Fox N, et al. Why has therapy development for dementia failed in the last two decades?Alzheimers Dement 2016; 12: 60-4. doi: 10.1016/j.jalz.2015.12.003.
55. Shah H, Albanese E, Duggan C, et al. Research priorities to reduce the global burden of dementia by 2025. Lancet Neurol 2016; 15: 1285-94. doi: 10.1016/S1474-4422(16)30235-6.
56. Winblad B, Amouyel P, Andrieu S, et al. Defeating Alzheimer?s disease and other dementias: a priority for European science and society. Lancet Neurol 2016; 15: 455-532. doi: 10.1016/S1474-4422(16)00062-4.